MannKind Earnings and Clinical Trial
Results Conference Call
Wednesday, August 14, 2013
“As you can tell from the data we are very pleased with the outcome of these trials, and we now expeditiously proceed to file an amended new drug application for a planned early in the 4th quarter. But now let me briefly address the status of new partnership efforts for Affreza: As we have stated before we have been facilitating the diligence efforts of various parties over the past several months, while other partners have stated that they would initiate or resume diligence activities upon the availability of phase 3 data. Now that the data is available we are picking up a formal partnering process intended to allow multiple potential partners to evaluate the Affreza opportunity simultaneously. We have engaged (William? & Company) to run this process and to advise us with respect to (…?…) proposals put forth by potential partners. Our goal is to secure a partner that has the right capabilities, the right approach to diabetes therapy to make Affreza the commercial success we know that it can be. With those comments I will now turn the call over to Al”
-Hakan S. Edstrom
President and Chief Operating Officer
Shorts have a very limited time to operate their dirty game.
I agree about "The Most Important Financial Component Of The Call". The suspense is: Who's that Partner?
Any guess? Should we expect the the announcement before the NDA submittal? From previous CC's, I had the feeling that the Partnership will be announced well before the NDA application.
Sentiment: Strong Buy
Shorts have a limited time frame in which to play this game. Options experimentation (OPEX) this month is 8/17 and maximum pain is $7.00 The difference between max worthless options between 6.50 and 7.00 is negligible, so this could very well end up right at 6.75
I can not see the future beyond that point. This may be your last chance to buy under 7.00 or it may not be. What I do know it that Mannkind is being courted by multiple large partners and is a takeover target as well. I know that the NDA submission will be a positive catalyst and that it will happen "early in the 4th quarter" They may just get this done ahead of schedule.
Shorts have a limited time here.